Smith & Nephew-J&J Orthopaedics Merger Talks Collapse
The proposed combination, which would have created a $34 billion transatlantic medical technology company, unravelled after Smith & Nephew refused to agree to its former CEO leading the merged business, the Financial Times reported.
The proposed combination of Johnson & Johnson’s NYSE:JNJ orthopaedics business and Smith & Nephew LSE:SN. would have created a $34 billion transatlantic medical technology company. Talks broke down after Smith & Nephew refused to accept its former CEO as head of the combined business, the Financial Times reported.